pENTR2b-Lifeact-mNeonGreen
(Plasmid
#225496)
-
PurposeExpression of Lifeact-mNeonGreen (Gateway entry vector)
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 225496 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepENTR2b
-
Vector typeGateway entry vector
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameLifeact
-
Tag
/ Fusion Protein
- mNeonGreen
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Kpn1 (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer cmv
- (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
First, gene blocks containing the lifeact sequence (Riedl et al., 2008) in frame with mNeonGreen (Shaner et al., 2013) and flanked with Kpn1 and Xho1 restriction sites were purchased from IDT (Integrated DNA Technologies, Inc.). Through enzymatic digestion (Kpn1, ThermoFisher Scientific, FD0524, and XhoI, ThermoFisher Scientific, FD0694) of the two sites on both gene blocks and the pENTR2b entry vector (ThermoFisher Scientific, A10463), we obtained pENTR2b-Lifeact-mNeonGreen.
Please visit https://doi.org/10.1101/2024.09.30.615654 for the bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pENTR2b-Lifeact-mNeonGreen was a gift from Guillaume Jacquemet (Addgene plasmid # 225496 ; http://n2t.net/addgene:225496 ; RRID:Addgene_225496) -
For your References section:
Fast label-free live imaging with FlowVision reveals key principles of cancer cell arrest on endothelial monolayers. Follain G, Ghimire S, Pylvanainen JW, Vaitkeviciute M, Hidalgo-Cenalmor I, Wurzinger D, Guzman C, Conway JRW, Dibus M, Harkonen J, Oikari S, Rilla K, Salmi M, Ivaska J, Jacquemet G. EMBO J. 2026 Jan 6. doi: 10.1038/s44318-025-00678-9. 10.1038/s44318-025-00678-9 PubMed 41495248